Drug
Metyrapone 250 mg Oral Tablets
Metyrapone 250 mg Oral Tablets is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph phase_4
1
25%
Ph early_phase_1
2
50%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)
Trials by Status
not_yet_recruiting125%
recruiting125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_4
Metyrapone Versus Osilodrostat in Patients With Metabolic Autonomous Cortisol Secretion (MACS)
NCT07268222
not_yet_recruitingphase_2
Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
NCT07138274
completedearly_phase_1
The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)
NCT05919992
completedearly_phase_1
Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals
NCT05167084
Clinical Trials (4)
Showing 4 of 4 trials
NCT07268222Phase 4
Metyrapone Versus Osilodrostat in Patients With Metabolic Autonomous Cortisol Secretion (MACS)
NCT07138274Phase 2
Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
NCT05919992Early Phase 1
The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)
NCT05167084Early Phase 1
Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4